Evidence map›Paper›PMID 39752924›Full record

ArticleDrug and alcohol dependence2025

The role of glucocorticoid and nicotinic acetylcholine receptors in the reward-enhancing effects of nicotine in the ICSS procedure in male and female rats.

Ranjithkumar Chellian, Azin Behnood-Rod, Adriaan W Bruijnzeel

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Ranjithkumar ChellianDepartment of Psychiatry, University of Florida, Gainesville, FL, USA.
Azin Behnood-RodDepartment of Psychiatry, University of Florida, Gainesville, FL, USA.
Adriaan W BruijnzeelDepartment of Psychiatry, University of Florida, Gainesville, FL, USA. Electronic address: awbruijn@ufl.edu.

Funding

Crosstalk between dopamine and glucocorticoids in high levels of nicotine intake and anhedonia in ratsR01DA046411 · NIDA · UNIVERSITY OF FLORIDA · PI BRUIJNZEEL, ADRIAAN WILLEM · 2019 to 2024
$1.7M
NIDA NIH HHS R01 DA046411
6 · The paper itself

Abstract

Tobacco use disorder is a chronic disorder that affects more than one billion people worldwide and causes the death of millions each year. The rewarding properties of nicotine are critical for the initiation of smoking. Previous research has shown that the activation of glucocorticoid receptors (GRs) plays a role in nicotine self-administration in rats. However, the role of GRs in the acute rewarding effects of nicotine are unknown. In this study, we investigated the effects of the GR antagonist mifepristone and the nicotinic acetylcholine receptor (nAChR) antagonist mecamylamine on the reward-enhancing effects of nicotine using the intracranial self-stimulation (ICSS) procedure in adult male and female rats. The rats were prepared with ICSS electrodes in the medial forebrain bundle and then trained on the ICSS procedure. Nicotine lowered the brain reward thresholds and decreased response latencies similarly in male and female rats. These findings suggest that nicotine enhances the rewarding effects of ICSS and has stimulant properties. Treatment with the GR antagonist mifepristone did not affect the reward-enhancing effects of nicotine but increased response latencies, suggesting a sedative effect. Mecamylamine prevented the nicotine-induced decrease in brain reward thresholds and response latencies, but did not affect the brain reward thresholds or response latencies of the control rats. These findings suggest that the rewarding effects of nicotine are mediated via the activation of nAChRs, and that the activation of GRs does not contribute to the acute rewarding effects of nicotine. These studies enhance our understanding of the neurobiological mechanisms underlying tobacco use disorder.

Indexed as

NicotineNicotinic AgonistsReceptors, GlucocorticoidReceptors, NicotinicRewardSelf StimulationAnimalsFemaleMaleMecamylamineMifepristoneNicotinic AntagonistsRatsRats, Sprague-DawleySelf AdministrationMecamylamineMifepristoneNicotineNicotinic AgonistsNicotinic AntagonistsReceptors, GlucocorticoidReceptors, NicotinicICSSMecamylamineMifepristoneNicotineRatsRewardSedationSex

Identifiers

PMID39752924
PMCPMC13169512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.